Publications by authors named "Christopher A Berger"
Page 1 of 1
Synopsis of recent research by authors named "Christopher A Berger"
Research Focus
: Christopher A Berger's recent research primarily targets the implementation and optimization of tuberculosis (TB) preventive treatments, particularly the 3HP (isoniazid-rifapentine) regimen among people living with HIV in Uganda, exploring factors that influence treatment delivery, acceptance, and completion rates.
Key Findings
: His studies reveal that various delivery strategies, such as facilitated directly observed therapy (DOT) and self-administered therapy (SAT), significantly impact patient acceptance and completion of 3HP treatment. Qualitative assessments highlight barriers and facilitators from both patient and health worker perspectives, informing future implementation efforts.
Adverse Events Analysis
: Additionally, Berger's research documents the types, frequency, and timing of adverse events related to 3HP therapy in real-world settings, emphasizing the necessity for ongoing monitoring as countries scale up TB prevention programs in high-burden contexts.
